Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC), including the nivolumab 1 mg/kg + ipilimumab 3 mg/kg expansion from CheckMate 032 Meeting Abstract

  

Authors:	Rosenberg, J. E.; Sharma, P.; de Braud, F. G. M.; Basso, U.; Calvo, E.; Bono, P.; Morse, M.; Ascierto, P. A.; Lopez-Martin, J. A.; Brossart, P.; Rohrberg, K. S.; Reguart, N.; Lin, W. H.; Meadows-Shropshire, S.; Saci, A.; Callahan, M.; Siefker-Radtke, A. O.
Abstract Title:	Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC), including the nivolumab 1 mg/kg + ipilimumab 3 mg/kg expansion from CheckMate 032
Meeting Title:	43rd ESMO Congress (ESMO 2018)
Journal Title:	Annals of Oncology
Volume:	29
Issue:	Suppl. 8
Meeting Dates:	2018 Oct 19-23
Meeting Location:	Munich, Germany
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2018-10-01
Start Page:	mdy424.038
Language:	English
ACCESSION:	WOS:000459277304391
PROVIDER:	wos
DOI:	10.1093/annonc/mdy424.038
Notes:	Meeting Abstract: LBA32 -- Appears on page viii725 of the abstract book -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/145105